Join us in warmly welcoming Didier Masson as he steps into his new role as Chief Operating Officer (COO) at Astraveus. Didier will use his vast experience in driving product & supply chain development through the next phases of industrialization and commercialization of Lakhesys – The Benchtop Cell Factory™.
He joins Astraveus with extensive professional journeys including several leadership roles within the pharma, biotech and medtech industries. With a recent COO tenure at Quantoom Biosciences, Didier is adept at crafting strategy development and guiding critical operations. With over 25 years of operational management experience, his know-how includes industrialization of bioprocessing instrumentation for business scale-up needs, and compliance with GMP and ISO standards such as ISO13485.
Speaking about the new COO appointment, Astraveus CEO and founder Jérémie Laurent adds, ‘We are thrilled to welcome Didier during a pivotal phase in our evolution, as we transition into user demonstration testing for our pioneering CAR T manufacturing system. Didier brings a track record of early-stage enterprise experience and knowledge on scaling-up of life science instrumentation businesses, this will be critical to our success moving forward.’
Please join us in welcoming Didier to Astraveus and wishing him every success in his new role!